Elkem Asa Ord (ELKEF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to Elkem's fourth quarter results presentation. My name is Audja Lyngstad and I'm responsible for investor relations in Elkem. Today's presentation has been extended because Elkem has reached a significant milestone to sell the majority of its silicones division to Bluestar. But before we present the details of that transaction, we will take you through the fourth quarter results. As usual, we will go through the highlights for the quarter and give you an update on the markets and the first quarter outlook. CEO Helge Olsen will take us through the first part of this presentation before CFO Morten Viga will present Elkem's fourth quarter results in more detail. We will open for Q&A after the presentation of the sales of the silicones division. So with that, I give the word to CEO Helge Olsen. Yeah, thank you, Edgar, and good morning and welcome, everyone. So, as already indicated by Odger, we have the pleasure of announcing that we've entered into a sales agreement with China National Blue Star, our majority shareholder, for a sale of most of the silicones division. This transaction will be settled through a redemption of all of Blue Star's shares in Elkem. And as already mentioned, we will come back to the details later in the presentation about this transaction. The result for the quarter was relatively strong, given the current market conditions. And I think we can say that, as most of our competitors in Europe have temporarily or permanently curtailed production, while we have throughout the quarter maintained close to full capacity utilization. The EBITDA for the fourth quarter ended up at 890 million Norwegian kroner, which gave an EBITDA margin of 12% for the group. And if you exclude silicones, which is reclassified as assets held for ...